TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says. November 23, 2005
